Drugs Made In America Acquisition DMII
NASDAQ DMII
$10.14 +0.02 (+0.20%)
At close: Aug 20, 2026 · 4:00 PM EDT

Drugs Made In America Acquisition (DMII) Total Current Liabilities (2024 - 2025)

Drugs Made In America Acquisition (DMII) posted quarterly Total Current Liabilities of $300864.0 for Q4 2025, up 18.09% year-over-year from $254783.0 in Q4 2024, and down 55.58% quarter-over-quarter from $677345.0 in Q3 2025.

Drugs Made In America Acquisition (DMII) Total Current Liabilities (2024 - 2025) Analysis & Trends

Drugs Made In America Acquisition (DMII) has reported Total Current Liabilities for 2 consecutive years, with $300864.0 the latest figure, recorded in Q4 2025.

  • In Q4 2025, Total Current Liabilities rose 18.09% year-over-year to $300864.0; the TTM figure through Dec 2025 stood at $300864.0 (up 18.09% YoY), while the FY2025 annual figure was $300864.0, up 18.09% from the prior year.
  • Total Current Liabilities fell to $300864.0 in Q4 2025 per DMII's latest filing, from $677345.0 in the prior quarter.
  • Across five years, Total Current Liabilities topped out at $677345.0 in Q3 2025 and bottomed at $254783.0 in Q4 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Current Liabilities (Qtr)
1 Launch Two Acquisition 557.86 Mn 557.86 Mn - 281,435.00
2 Drugs Made In America Acquisition 507.00 Mn 507.00 Mn - 644,574.00
3 Cantor Equity Partners IV 467.55 Mn 467.55 Mn - -
4 GP-Act III Acquisition 401.06 Mn 401.06 Mn - 2.38 Mn
5 Aldel Financial 397.49 Mn 397.49 Mn - 20,057.00
6 Gores Holdings X 381.05 Mn 380.85 Mn - 3.69 Mn
7 Agriculture & Natural Solutions Acquisition 377.29 Mn 377.04 Mn - 22.16 Mn
8 Blue Water Acquisition Corp. III 342.12 Mn 342.08 Mn - 748,633.00
9 Berto Acquisition 313.96 Mn 313.81 Mn - 2.41 Mn
10 New Providence Acquisition Corp. III 313.81 Mn 313.81 Mn - 1.40 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 300,864.00
Sep 30, 2025 677,345.00
Dec 31, 2024 254,783.00